Dan Brennan
Stock Analyst at UBS
(0)
# 3183
Out of 5,291 analysts
109
Total ratings
38.60%
Success rate
0.68%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Maravai LifeSciences | Maintains: Neutral | 8 3 | 2.35 | 6.38% | 4 | Mar 21, 2025 | |
Tempus AI | Reinstates: Buy | 74 | 47.87 | 54.59% | 2 | Feb 5, 2025 | |
GeneDx Hldgs | Maintains: Strong Buy | 75 118 | 92.19 | 28% | 3 | Jan 7, 2025 | |
Exact Sciences | Maintains: Strong Buy | 82 86 | 43.65 | 97.02% | 6 | Nov 26, 2024 | |
Natera | Maintains: Strong Buy | 155 175 | 143.98 | 21.54% | 4 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 240 250 | 155.6 | 60.67% | 5 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 72 70 | 42.06 | 66.43% | 1 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 166 177 | 80.01 | 121.22% | 10 | Nov 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 141 144 | 105.68 | 36.26% | 3 | Nov 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 363 410 | 361.6 | 13.38% | 3 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 310 315 | 205.69 | 53.14% | 5 | Oct 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 153 160 | 116.59 | 37.23% | 12 | Aug 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 41 42 | 43.1 | -2.55% | 1 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 28 30 | 8.87 | 238.22% | 1 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 28 31 | 16.19 | 91.48% | 3 | Jul 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 648 658 | 499.72 | 31.67% | 8 | Jul 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 48 51 | 44.96 | 13.43% | 2 | Jul 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 3 | 0.67 | 317.91% | 1 | May 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 20 | 9.61 | 108.12% | 6 | May 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 57 32 | 9.18 | 248.58% | 4 | May 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 545 546 | 291.88 | 87.06% | 4 | Dec 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 6 2 | n/a | n/a | 2 | Nov 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | 1.5 | 366.67% | 1 | May 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 13 15 | 1.14 | 1215.79% | 1 | Mar 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 7 | n/a | n/a | 4 | Mar 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 8 3 | n/a | n/a | 3 | Jul 26, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 207 232 | 179.12 | 29.52% | 5 | Mar 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 770 880 | 1176.24 | -25.19% | 3 | Oct 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 34 | n/a | n/a | 1 | Mar 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 78 90 | n/a | n/a | 1 | Oct 5, 2016 |